There is a silver lining in the fight against the coronavirus epidemic after an international pharmaceutical company developed the first antiretroviral drug that would be effective against the virus.
A clinical trial of Merck’s drug Molnupiravir pill has been shown to reduce the risk of hospitalization and death in people with Covi-19.
Merck announced Friday that it is seeking emergency approval for the pill from the Food and Drug Administration (FDA).
If approved for emergency use, the drug will be given to high-risk individuals, as soon as they show symptoms of Covid-19.
Molnupiravir will be the first pill to treat Covid-19, with clinical trials showing it being able to reach a larger population, compared to current monoklonal antidepressant therapy, widely used in the United States and around the world.
“I think this will translate into thousands of lives being saved around the world, where there is limited access to one body’s antibodies, and in this country as well,” said Dr. Robert Shafer, an infectious disease specialist at Stanford University, The New York Times.